CD4 and influenza: Efforts into producing a more effective influenza vaccine have found that an intranasal nanoparticle vaccination elicited a persistent, polyfunctional CD4+ T cell response producing IFNγ and TNFα in murine models, which mediates survival from a lethal challenge with H1N1 influenza virus (Nelson et al., 2021).